Searched for
NEURO DEGENERATIVE DISEASES
Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...- Suven Life gets product patents from Australia, Hong KongThese patents are valid till 2036 and 2033 respectively, the company said in a BSE filing.
- Suven Life gets patent from New Zealand for neurological drugSuven Life said it has been granted "one product patent from New Zealand corresponding to the NCEs for the treatment of disorders associate...
- Suven Life gets patents for anti-neuro degeneration moleculeThe molecules are being developed for the treatment of cognitive impairment associated with neuro-degenerative disorders like Alzheimer's d...
- Suven Life gets patent for anti-neuro degenerative drugSuven Life said it has been granted "one product patent from the US corresponding to the new chemical entities (NCEs) for the treatment of ...
- Suven Life up 5% on patents for neuro-degenerative drugThe company was granted patents from Europe and Israel corresponding to the NCEs for the treatment of disorders associated with neuro-degen...
- Suven Life Sciences gets patent for neuro-degenerative drugIn a BSE filing today, it said it has been granted "one product patent from Europe and two patents from Eurasia corresponding to New Chemic...
- Suven Life gets patents for neuro-degenerative drugWith these new patents, Suven has a total of 24 granted patents from Australia, 17 from Eurasia and 9 from Israel and 24 from the US.
- Suven Life shares end with 2% gains on getting patent for drugShares of Suven Life Sciences ended with nearly 2 per cent gains today as the company won patent for a drug, used in treatment of neuro-deg...
- Suven Life shares surge 5% on getting patent for drugThe company has been granted "one product patent from China, one product patent from Eurasia and one product patent from Hong Kong correspo...
- Suven Life gets patent for neuro-degenerative drugSuven Life Sciences has been granted a patent each by China, Eurasia and Hong Kong for a drug used in the treatment of neuro-degenerative d...
- Suven Life Sciences gets patent for neuro-degenerative drugWith these new patents, Suven has a total of 23 granted patents from Australia and 22 from Canada.
- Suven Life shares gain on patent rights in foreign countriesSuven Life Sciences shares rose over 1 per cent after the drug firm got patent rights in foreign countries for a neuro-degenerative drug.
- Suven Life Sciences gets patent for neuro-degenerative drugDrug firm Suven Life Sciences has been granted a patent each by Eurasia, Europe, Israel and Macau for a drug used in the treatment of neuro...
- Suven Life shares close 7.5% up on securing molecule patentThe stock surged 7.09 per cent to settle at Rs 252.20 on the BSE. During the day, it jumped 8.66 per cent to Rs 255.90.
- Suven gets patents for neuro-degenerative disorder drugThese granted patents are exclusive intellectual property of Suven and are achieved through the internal discovery research efforts.
- Suven Life gets patents for molecules in three countriesThe firm has been granted patents each by Canada, Japan and Korea for molecules, aimed to be developed as drugs, for the treatment of neuro...
- Suven Life Sciences gets patents for neuro-degenerative drugNeuro-degenerative ailments include Alzheimer's disease, Schizophrenia and Parkinson's disease.
- Suven gets four new drug molecule patents in four countriesSuven Life Sciences Ltd gets four product patents one each from Australia, Canada, Korea and New Zealand for their new drug molecules (New ...
- Suven gets patents for 3 NCEs for neuro disorders in IndiaSuven Life Sciences has received product patents in India for three new chemical entities 208688, 208714 and 209540 for treatment of disord...
Load More
